DIABETES Now Has A CURE? Hope Rises As Doctors Reveal Potential Drug That Could Be The Final Cure
Diabetes, a chronic condition affecting over 800 million individuals worldwide, has seen a staggering rise from 190 million cases in 1990. With its immense global impact, researchers have tirelessly pursued a cure. Now, a groundbreaking treatment combining harmine and pancreatic alpha cells is offering hope for millions, potentially transforming diabetes management.
Harmine, a drug identified in 2015, has shown immense potential in regenerating pancreatic beta cells, responsible for insulin production. Classified as a DYRK1A inhibitor, harmine stimulates beta cell growth. When combined with GLP- 1 receptor agonists (GLP- 1RAs) like semaglutide or exenatide, its regenerative effects are amplified, boosting beta cell mass by up to 700%.
Recent discoveries have added an exciting layer to this advancement. Researchers found that alpha cells, another type of pancreatic cell, can be transformed into beta cells. Given the abundance of alpha cells in individuals with diabetes, this discovery could lead to restoring natural insulin production, reducing or eliminating the need for daily injections.
” This is an exciting finding that shows harmine- family drugs may induce lineage conversion in human pancreatic islets, ” stated Esra Karakose, a lead researcher in the study. ” It may mean people with all forms of diabetes have a large potential ‘ reservoir’ for future beta cells, just waiting to be activated by drugs like harmine. ”
The implications are monumental. For millions currently dependent on insulin injections, this breakthrough could simplify treatment to a daily pill. Combined with GLP- 1RAs, such a treatment promises an accessible, cost- effective solution, drastically reducing the physical and financial burdens of diabetes care.
What’ s your thoughts about this drug, could it be the final answer to diabetes?